Elicio Therapeutics Inc (ELTX)
10.01
+0.63
(+6.72%)
USD |
NASDAQ |
May 17, 16:00
10.01
0.00 (0.00%)
After-Hours: 17:20
Elicio Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -0.032M |
June 30, 2023 | 0.013M |
September 30, 2022 | -0.559M |
Date | Value |
---|---|
June 30, 2022 | -0.559M |
March 31, 2021 | -0.0759M |
March 31, 2020 | -0.0648M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.559M
Minimum
Jun 2022
0.013M
Maximum
Jun 2023
-0.2129M
Average
-0.0703M
Median
Cash from Investing (Quarterly) Benchmarks
Immuneering Corp | 21.39M |
Outlook Therapeutics Inc | -- |
Amylyx Pharmaceuticals Inc | 0.819M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
Free Cash Flow Yield | -123.3% |